Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Laura Goea"'
Autor:
Jürgen Klar, Laura Goea, Frank Eitner, Manuel Grundmann, Mira Pavkovic, Karoline Droebner, Peter Kolkhof, Elke Hartmann, Johannes Nordlohne
Publikováno v:
American journal of nephrology. 52(7)
Introduction: The nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone and sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated clinical benefits in chronic kidney disease patients with type 2 diabetes. Precise molecular
Autor:
Pierbruno Ricci, Laura Goea, Jens Drube, Joost P. Schanstra, Petra Zürbig, Stéphane Decramer, Giuseppe Remuzzi, Magdalena Krochmal, Franz Schaefer, Martin Pejchinovski, Harald Mischak, Pedro Magalhães, Lars Pape, Muriel Umbhauer, Maria Rosa Caruso, Silvia Cereghini, Iwona Belczacka, Erica Daina
Publikováno v:
Scientific Reports
Scientific Reports, 2019, 9 (1), pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Scientific Reports, Nature Publishing Group, 2019, 9, pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Nature Publishing Group, 2019, 9 (1), pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Scientific Reports, 2019, 9 (1), pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Scientific Reports, Nature Publishing Group, 2019, 9, pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Nature Publishing Group, 2019, 9 (1), pp.2225. ⟨10.1038/s41598-019-38713-5⟩
Renal Cysts and Diabetes Syndrome (RCAD) is an autosomal dominant disorder caused by mutations in the HNF1B gene encoding for the transcriptional factor hepatocyte nuclear factor-1B. RCAD is characterized as a multi-organ disease, with a broad spectr